Applied BioCode Company Description

Applied BioCode Corporation designs, develops, and commercializes multiplex diagnostic testing products in California.

The company’s products include the BioCode MDx 3000 system, an automated molecular diagnostic system that automates the PCR amplification, hybridization, and detection steps of molecular testing; and the BioCode 2500 analyzer, a system that reads barcoded magnetic beads (BMB) and displays the barcode and fluorescence intensity for each BMB.

It develops assays, such as BioCode SARS-CoV-2 Assay, a nucleic acid assay for the detection of SARS-CoV-2 nucleic acid in nasopharyngeal swabs; and CoV-2 Flu Assay for detection of RNA and various Influenza, as well as offers gastrointestinal and respiratory pathogen panel related products.

In addition, the company provides general purpose reagents and manufactures 28 fungal analyte specific reagents.

Further, it offers barcoded bead related accessories. Applied BioCode Corporation is based in Santa Fe Springs, California.

Applied BioCode Corporation

Country	Cayman Islands
Industry	Medical Devices
Sector	Healthcare
CEO	Winston Z. Ho

Contact Details

Address: 12130 Mora Dr. Santa Fe Springs, 90670 United States
Phone	562 777 9800
Website	apbiocode.com

Stock Details

Ticker Symbol	6598
Exchange	Taiwan Stock Exchange
Fiscal Year	January - December
Reporting Currency	TWD
ISIN Number	KYG0488D1051
SIC Code	2835

Key Executives

Name	Position
Dr. Winston Z. Ho Ph.D.	Founder, Chief Executive Officer, President and Director
Jaca Liang-Kai Huang	Chief Financial Officer and Corporate Governance Officer
Yu-Tsung Chou	Chief Information Officer
Dr. Beth Laderman Ph.D.	Chief Scientific Officer
Parisa Hanachi Ph.D.	Vice President of Marketing
Jim Leigh	Vice President of Sales
Julian Sanchez	Senior Director of Human Resources
Ruei-E Tang	Administration Division Director
Ingrid Joseph	Administration Division Director